Evaluating Safety and Immune Response of Janssen, Moderna, Pfizer/BNT, and Novavax COVID-19 Vaccines for Same and Mixed Boosters in Adolescents and Adults Aged 12-64 With and Without HIV in Kenya, DRC, and Rwanda

NCT07408297 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

1919

Enrollment

OTHER

Sponsor class

Conditions

COVID -19
SARS CoV 2 Infection

Interventions

BIOLOGICAL: Janssen Ad26COVS1
BIOLOGICAL: Pfizer-BioNTech vaccine COVID-19 vaccine
BIOLOGICAL: Inactivated Sinopharm or Sinovac COVID-19 vaccine

Sponsor

Victoria Biomedical Research Institute

Collaborators

[object Object]
[object Object]
[object Object]